Artivila Biopharma
PrivateLast Round
Series A
Jun 25, 2026
Total Funding Raised
$12.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Artivila Biopharma is a biotechnology company that develops innovative drugs for autoimmune diseases, neurodegenerative diseases, and oncology using an AI-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artivila Biopharma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Artivila Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 25, 2026 | ||||
| VC Round | Mar 31, 2022 | ||||
| VC Round | Mar 31, 2021 |
Artivila Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | VC Round |
| Hike Capital | VC Round |
| 幂方资本 | VC Round |
| Yijing Capital | VC Round |
| Shanghai Honghui Asset Management | VC Round |
| 松禾资本 (Green Pine Capital Partners) | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
$13M round led by Green Pine Capital Partners
Artivila Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artivila Biopharma's valuation, stock price, and market status.